Operating Lease, Right-of-Use Asset of EUPRAXIA PHARMACEUTICALS INC. from 31 Dec 2021 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: EUPRAXIA PHARMACEUTICALS INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 31 Dec 2025.
EUPRAXIA PHARMACEUTICALS INC. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $152,697, a 128% increase year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

EUPRAXIA PHARMACEUTICALS INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$152,697	+$85,674	+128%	31 Dec 2025	40-F	13 Mar 2026	2025	FY
Q4 2024	$67,023	+$20,363	+44%	31 Dec 2024	40-F	13 Mar 2026	2025	FY
Q4 2023	$46,660	-$40,626	-47%	31 Dec 2023	40-F	13 Mar 2026	2025	FY
Q4 2022	$87,286	-$44,734	-34%	31 Dec 2022	40-F	20 Mar 2025	2024	FY
Q4 2021	$132,020			31 Dec 2021	40-F	01 Apr 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.